Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision‐cut liver slices
Abstract Fibrotic processes in the liver of non‐alcoholic steatohepatitis (NASH) patients cause microcirculatory dysfunction in the organ which increases blood vessel resistance and causes portal hypertension. Assessing blood vessel function in the liver is challenging, necessitating the development...
Saved in:
Main Authors: | Anouk Oldenburger (Author), Gerald Birk (Author), Marco Schlepütz (Author), Andre Broermann (Author), Birgit Stierstorfer (Author), Steven S. Pullen (Author), Jörg F. Rippmann (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
by: Lian TY, et al.
Published: (2017) -
YC-1, a Nitric Oxide-Independent Activator of Soluble Guanylate Cyclase, Inhibits the Spontaneous Contractions of Isolated Pregnant Rat Myometrium
by: Ali Cetin, et al.
Published: (2004) -
The soluble guanylate cyclase stimulator named vericiguat as an innovative heart failure therapy representative
by: Beata Jacuś, et al.
Published: (2021) -
Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy
by: Bo-ang Hu, et al.
Published: (2023) -
Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet‐fed rabbits
by: Masashi Tawa, et al.
Published: (2021)